Adnan Butt
Stock Analyst
(n/a)
# 4,425
Out of 4,433 analysts
7
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Downgrades: Neutral | n/a | $230.57 | - | 2 | Feb 22, 2019 | |
| ITRM Iterum Therapeutics | Initiates: Outperform | n/a | $1.41 | - | 1 | Jun 19, 2018 | |
| SCYX SCYNEXIS | Initiates: Buy | n/a | $2.77 | - | 1 | Oct 24, 2017 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $6.17 | - | 1 | Oct 24, 2017 | |
| CRIS Curis | Initiates: Buy | n/a | $11.80 | - | 1 | Oct 24, 2017 | |
| REGN Regeneron Pharmaceuticals | Initiates: Sector Perform | n/a | $982.29 | - | 1 | Sep 15, 2017 |
Biogen
Feb 22, 2019
Downgrades: Neutral
Price Target: n/a
Current: $230.57
Upside: -
Iterum Therapeutics
Jun 19, 2018
Initiates: Outperform
Price Target: n/a
Current: $1.41
Upside: -
SCYNEXIS
Oct 24, 2017
Initiates: Buy
Price Target: n/a
Current: $2.77
Upside: -
Ocular Therapeutix
Oct 24, 2017
Initiates: Buy
Price Target: n/a
Current: $6.17
Upside: -
Curis
Oct 24, 2017
Initiates: Buy
Price Target: n/a
Current: $11.80
Upside: -
Regeneron Pharmaceuticals
Sep 15, 2017
Initiates: Sector Perform
Price Target: n/a
Current: $982.29
Upside: -